nChroma Bio
nChroma
Boston, United States · Founded 2024 · $335.0M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 51–200
- Founded
- 2024
- Business Model
- B2B
- Website
- nchromabio.com
- Total Funding
- $335.0M
- Last Round
- $75.0M Corporate RoundDec 2024
- Rounds
- 3
About
nChroma Bio is a clinical-stage genetic medicines company developing targeted in vivo delivery systems and engineered epigenetic silencers for durable disease treatment. Its lead program, CRMA-1001, is a liver-directed epigenetic therapy in Phase 1/2 trials targeting a functional cure for chronic hepatitis B. The company combines lipid nanoparticle delivery with proprietary epigenetic editing to achieve durable gene silencing without altering the underlying DNA sequence.
Summary
nChroma Bio is a Biotech company based in Boston, United States, founded in 2024. It has raised $335.0M in total across 3 rounds, most recently a $75.0M Corporate Round round in Dec 2024. Investors include GV (Google Ventures), Flagship Pioneering and ARCH Venture Partners.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Dec 2024
Sign up to see all 3 rounds
Series A through Corporate Round — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Long-read DNA sequencing company providing advanced systems for complete and accurate genome, tra...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/nchroma-bio"><img src="https://indexed.vc/api/badge/company/nchroma-bio" alt="nChroma Bio on Indexed.vc" width="260" height="76" /></a>